PDF factsheet
      Z

cholesterol lowering intervention in heart failure for elderly , clinical trials results

rosuvastatin versus placebo
CORONA, 2007
NCT00206310
rosuvastatin 10mg/d
versus
placebo
patients at least 60 years of age with NYHA class II, III, or IV ischemic, systolic heart failuredouble blind
Follow-up duration: 32.9 months median

  Options


in first

in second

  Filter